Comparison of Virologic and Immunologic Responses to Raltegravir and Dolutegravir in the Gastrointestinal Tract of HIV-Positive Adults

Clinical trial NCT02218320 · COMPLETED

Trial details

NCT number: NCT02218320
Sponsor: University of North Carolina, Chapel Hill
Status: COMPLETED
Study type: OBSERVATIONAL

Human Immunodeficiency Virus

Start date: 2014-10-01
Primary completion: 2015-10-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.